Zobrazeno 1 - 8
of 8
pro vyhledávání: '"P. Peter Borek"'
Autor:
Piotr J. Bachul, Karolina Golab, Lindsay Basto, Steven Zangan, Jordan S. Pyda, Angelica Perez-Gutierrez, Peter Borek, Ling-Jia Wang, Martin Tibudan, Dong-Kha Tran, Roi Anteby, Gabriela S. Generette, Jędrzej Chrzanowski, Wojciech Fendler, Laurencia Perea, Kumar Jayant, Aaron Lucander, Celeste Thomas, Louis Philipson, J. Michael Millis, John Fung, Piotr Witkowski
Publikováno v:
Cell Transplantation, Vol 30 (2021)
A recent randomized, multicenter trial did not show benefit of a CXCR1/2 receptor inhibitor (Reparixin) when analysis included marginal islet mass (>3,000 IEQ/kg) for allotransplantation and when immunosuppression regimens were not standardized among
Externí odkaz:
https://doaj.org/article/ea2f1285dd134ef0ab79aab288bd503c
Autor:
Paul D. Ziegler, Bruce L. Wilkoff, P. Peter Borek, Kevin T. Ousdigian, J. Thomas Heywood, Jodi Koehler
Publikováno v:
Circulation: Arrhythmia and Electrophysiology. 7:370-376
Background— We classified patients’ atrial fibrillation (AF), assessed its impact on biventricular pacing (BIVP%), and determined whether AF classification or BIVP% independently correlate with mortality in cardiac resynchronization therapy defib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d051d3a15a050d3d5fe1d9631f9d4bd6
https://doi.org/10.1161/circep.113.001212
https://doi.org/10.1161/circep.113.001212
Autor:
Oussama M. Wazni, David O. Martin, P. Peter Borek, Khaldoun G. Tarakji, Daniel J. Cantillon, Edmond M. Cronin, Jessen Jacob, Michael Brunner, Thomas Callahan, Valeria E. Duarte, Walid Saliba, Bryan Baranowski, Mohamed Kanj, Mark Niebauer, Bruce L. Wilkoff
Publikováno v:
Heart Rhythm. 10:1444-1450
Background Comparative safety and efficacy associated with transvenous lead extraction (TLE) of recalled and non-recalled implantable cardioverter-defibrillator (ICD) leads has not been well characterized. Objectives To compare the indications, techn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe3e46140ad21dc8700acfd226d8283d
https://doi.org/10.1016/j.hrthm.2013.06.021
https://doi.org/10.1016/j.hrthm.2013.06.021
Autor:
John Rickard, Oussama M. Wazni, Michael Brunner, Bryan Baranowski, Gregory Jackson, David O. Martin, Edmond M. Cronin, P. Peter Borek, Bruce L. Wilkoff, Khaldoun G. Tarakji
Publikováno v:
Journal of Cardiovascular Electrophysiology. 23:1213-1216
LV Lead Extraction and Reimplantation. Background: Early series of biventricular device removal have contained mostly younger cardiac venous (CV) left ventricular leads and few have reported on rates of successful reimplantation. Methods and Results:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebe7b35aca98696cf75f7484fda0b8f1
https://doi.org/10.1111/j.1540-8167.2012.02392.x
https://doi.org/10.1111/j.1540-8167.2012.02392.x
Autor:
P. Peter Borek, Deepak L. Bhatt, Arman T. Askari, Anthony A. Bavry, Girish R. Mood, Dharam J. Kumbhani
Publikováno v:
American Journal of Cardiovascular Drugs. 7:135-141
This study sought to determine if the initiation of statin (HMG-CoA reductase inhibitor) therapy during acute coronary syndromes reduces long-term mortality and other adverse cardiac outcomes. Initiation of statin therapy during acute coronary syndro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ef43dd046187f2737c8c277ea643fe7
https://doi.org/10.2165/00129784-200707020-00005
https://doi.org/10.2165/00129784-200707020-00005
Autor:
P. Peter Borek, Albert Sey, Niraj Varma, Mohamed Kanj, Mingyuan Shao, Walid Saliba, Mina K. Chung, Jay Sengupta, Mark Niebauer, Ayman A. Hussein, John Rickard, Bruce D. Lindsay, Samir Alam, Bernard Abi-Saleh, Mariam Diab, Bryan Baranowski, Oussama M. Wazni, David O. Martin, Maurice Khoury, Patrick J. Tchou, Thomas Callahan, Mohamed Bassiouny, Thomas Dresing
Publikováno v:
Circulation: Arrhythmia and Electrophysiology. 6
Thank you for giving us the opportunity to respond to Dr Fauchier’s valid concerns. Dr Fauchier et al recommended holding dabigatran for ≥36 hours preablation and considering switching to weight-adapted LMWH (low-molecular-weight heparin). In add
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c1d30d9b2bf71fa98fba7f05ddb5fe5
https://doi.org/10.1161/circep.113.000701
https://doi.org/10.1161/circep.113.000701
Autor:
Mingyuan Shao, Maurice Khoury, Thomas Dresing, Ayman A. Hussein, Mohamed Kanj, Oussama M. Wazni, Thomas Callahan, Mina K. Chung, Bruce D. Lindsay, Mohamed Bassiouny, Jay Sengupta, Mark Niebauer, P. Peter Borek, Patrick J. Tchou, John Rickard, Bryan Baranowski, Samir Alam, Niraj Varma, Walid Saliba, Albert Sey, Mariam Diab, Bernard Abi-Saleh, David O. Martin
Background— Pulmonary vein isolation (PVI) for atrial fibrillation is associated with a transient increased risk of thromboembolic and hemorrhagic events. We hypothesized that dabigatran can be safely used as an alternative to continuous warfarin f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fbd88ec74ce42a323f431026790bd7e
https://europepmc.org/articles/PMC3688655/
https://europepmc.org/articles/PMC3688655/
Autor:
P. Peter Borek, Bruce L. Wilkoff
Publikováno v:
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 23(1)
Pacemaker and defibrillator therapy is on the rise as a result of expanding indications. Unfortunately, this trend is associated with an increased number of cardiac device-related complications. Lead failure, device infection and vascular complicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::841866b3761ee20da600348c77115cc0
https://pubmed.ncbi.nlm.nih.gov/18392929
https://pubmed.ncbi.nlm.nih.gov/18392929